This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Men's Health  • Men's Health, Other  • Oncology  • Skin Cancer  • Oncology, Other  • Dermatology  • Dermatologic Disorders  • Radiation Therapy  • Neoplasms  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Mark Eliason, MD; Anneli Bowen, MD; Lisa Hazard, MD; Wolfram Samlowski, MD

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The standard treatment for a verrucous carcinoma (also known as the giant condyloma of Buschke and Lowenstein) is surgical resection with 2-cm margins.¹ For advanced or unresectable penile carcinoma, a number of chemotherapy agents including cisplatin, methotrexate, fluorouracil, and bleomycin have demonstrated modest activity. The Southwest Oncology Group² performed the largest prospective clinical study of penile carcinoma and found an overall response rate of 32.5% and a complete response rate of 12.5%. It should be noted that this study was performed in patients with regionally advanced or metastatic squamous cell carcinoma (SCC). Based on improvements in chemoradiotherapy of nonpenile epithelial cancers, we evaluated whether this approach could be applied to a patient with advanced penile carcinoma who refused radical surgery.^3-4

Report of a Case

A 70-year-old white man was referred to our clinic for evaluation of a large, verrucous lesion centered at . . . [Full Text of this Article]

Comment

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?